Immune cells surrounding the myxoma displayed suppressive characteristics, potentially contributing to the tumor’s strategy of evading immunity, as evidenced by the impaired effector function of CD8 + T cells expressing GZMK and TOX highly. The gene discussed is GZMK; the disease is neoplasm.